跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT00595348
NCT00595348Unknown不适用

Korean Hereditary Breast Cancer Study

Korean Breast Cancer Study Group1 个研究点 分布在 1 个国家目标入组 2,250 人开始时间: 2007年11月最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
发起方
入组人数
2,250
试验地点
1
主要终点
Find out the prevalence of BRCA1/2 mutation of high risk breast cancer patients
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

  1. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients with family history of breast/ovarian cancer.
  2. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients without family history, but high risk of hereditary cancer.
  3. To evaluate the prevalence of BRCA1/2 mutation of family member of BRCA1/2 mutation.
  4. To evaluate the prevalence of ovarian cancer of population of above 3 groups.

详细描述

  1. To find founder mutation in Korean
  2. To correlation prevalence with risk evaluation
  3. To find risk factors concerning life style

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —（Adult, Older Adult）
性别
All
接受健康志愿者
是

入选标准

  • •Over 19 years old
  • •Agree to this study
  • •Breast cancer patient with family history of breast/ovarian cancer (1 subgroup)
  • •Breast cancer patient; young age (<40), bilateral, male, combined ovarian (2 subgroup)
  • •Family members with 1, 2 subgroups (3 subgroup)

排除标准

  • •Under 20 years old
  • •Unable to decide for oneself

结局指标

主要结局

Find out the prevalence of BRCA1/2 mutation of high risk breast cancer patients

时间窗: 6 years

次要结局

未报告次要终点

研究者

发起方
Korean Breast Cancer Study Group
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Genetic testing in breast cancer patients based on a home information package: DNA-direct.BRCA1/2, breast cancer, borstkanker, hereditary breast cancer, erfelijke borstkanker
NL-OMON22096MC St Radboud / Radboud University Medical Center (Nijmegen)150
已完成
不适用
BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian CancerTo Investigate the Prevalence of BRCA 1/2 Mutation Among Ovarian Cancer
NCT02963688Samsung Medical Center298
Unknown
不适用
Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic MutationBreast Cancer Metastatic
NCT04368442Samsung Medical Center583
已完成
不适用
Lessons Learned From the Family Gene ToolkitWomen With BRCA 1 or BRCA 2 MutationNon-tested Female Family Members
NCT02154633University of Michigan13
撤回
不适用
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation CarriersBRCA1 Mutation CarrierBRCA2 Mutation CarrierBreast Carcinoma
NCT00899145Gynecologic Oncology Group
Korean Hereditary Breast Cancer Study | 临床试验